Prostate cancer: MRI/US-guided biopsy--a viable alternative to TRUS-guidance
- PMID: 23938941
- DOI: 10.1038/nrurol.2013.179
Prostate cancer: MRI/US-guided biopsy--a viable alternative to TRUS-guidance
Comment on
-
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.Eur Urol. 2013 Nov;64(5):713-719. doi: 10.1016/j.eururo.2013.05.059. Epub 2013 Jun 12. Eur Urol. 2013. PMID: 23787357 Free PMC article. Clinical Trial.
Similar articles
-
Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.Investig Clin Urol. 2019 Jan;60(1):4-13. doi: 10.4111/icu.2019.60.1.4. Epub 2018 Dec 27. Investig Clin Urol. 2019. PMID: 30637355 Free PMC article. Review.
-
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.Eur Urol. 2015 Sep;68(3):438-50. doi: 10.1016/j.eururo.2014.11.037. Epub 2014 Dec 3. Eur Urol. 2015. PMID: 25480312 Review.
-
Words of wisdom. Re: Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy.Eur Urol. 2014 Jun;65(6):1218-9. doi: 10.1016/j.eururo.2014.02.025. Eur Urol. 2014. PMID: 24774825 No abstract available.
-
Has magnetic resonance-guided biopsy of the prostate become the standard of care?Eur Urol. 2013 Nov;64(5):720-1. doi: 10.1016/j.eururo.2013.06.050. Epub 2013 Jul 3. Eur Urol. 2013. PMID: 23845230 No abstract available.
-
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.Eur Urol. 2013 Nov;64(5):713-719. doi: 10.1016/j.eururo.2013.05.059. Epub 2013 Jun 12. Eur Urol. 2013. PMID: 23787357 Free PMC article. Clinical Trial.
Cited by
-
Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.Int J Mol Sci. 2023 Apr 10;24(8):7022. doi: 10.3390/ijms24087022. Int J Mol Sci. 2023. PMID: 37108185 Free PMC article.
-
Contemporary outcomes in the detection of prostate cancer using transrectal ultrasound-guided 12-core biopsy in Singaporean men with elevated prostate specific antigen and/or abnormal digital rectal examination.Asian J Urol. 2015 Oct;2(4):187-193. doi: 10.1016/j.ajur.2015.08.003. Epub 2015 Sep 3. Asian J Urol. 2015. PMID: 29264144 Free PMC article.
-
Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.Mol Pharm. 2017 Nov 6;14(11):3906-3915. doi: 10.1021/acs.molpharmaceut.7b00619. Epub 2017 Oct 25. Mol Pharm. 2017. PMID: 28976766 Free PMC article.
-
Direct magnetic resonance imaging-guided biopsy of the prostate: lessons learned in establishing a regional referral center.Transl Androl Urol. 2017 Jun;6(3):395-405. doi: 10.21037/tau.2017.01.14. Transl Androl Urol. 2017. PMID: 28725581 Free PMC article. Review.
-
Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.Int Braz J Urol. 2016 Sep-Oct;42(5):897-905. doi: 10.1590/S1677-5538.IBJU.2015.0204. Int Braz J Urol. 2016. PMID: 27532112 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical